CLINICAL_TRIALS
withdrawal
· 2024-10-16
Clinical Trial Update: Phase 1b/2a in SLE With Budoputug [Phase 1, Phase 2]
Summary
A Phase 1b/2a clinical trial of Budoputug for systemic lupus erythematosus has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tenet Medicines | Conditions: Systemic Lupus Erythematosus, SLE | Phase 1, Phase 2 | Status: WITHDRAWN